(Q44605531)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

1 reference

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Andreas Hochhaus

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Stefan W. Krause

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Müller MC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Gattermann N

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Lahaye T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Deininger MW

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Berndt A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Fruehauf S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Neubauer A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Fischer T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Hossfeld DK

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Schneller F

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Nerl C

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Sayer HG

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Waller C

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Aulitzky W

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

le Coutre P

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Freund M

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Merx K

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Paschka P

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

König H

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Kreil S

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Berger U

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Gschaidmeier H

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Hehlmann R

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

2392-2400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14523462%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

cites work

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Detection and quantification of residual disease in chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Practical management of patients with chronic myeloid leukemia receiving imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Perspectives on the development of a molecularly targeted agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Minimal Residual Disease after Bone Marrow Transplant for Chronic Myeloid Leukaemia Detected by the Polymerase Chain Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157

Polymerase chain reaction for detection of residual leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403157